Financial reports
10-Q
2021 Q1
Quarterly report
14 May 21
10-K
2020 FY
Annual report
15 Apr 21
NT 10-K
Notice of late annual filing
31 Mar 21
10-Q
2020 Q3
Quarterly report
13 Nov 20
10-Q
2020 Q2
Quarterly report
14 Aug 20
10-Q
2020 Q1
Quarterly report
15 May 20
10-K
2019 FY
Annual report
30 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
14 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
Current reports
8-K
Cardax Voluntarily Suspends SEC Reporting Obligations
11 Aug 21
8-K
Changes in Registrant's Certifying Accountant
1 Jul 21
8-K
Entry into a Material Definitive Agreement
13 Jan 21
8-K
Regulation FD Disclosure
18 Nov 20
8-K
Entry into a Material Definitive Agreement
15 May 20
8-K
Entry into a Material Definitive Agreement
20 Mar 20
8-K
Entry into a Material Definitive Agreement
27 Jan 20
8-K
Cardax, Inc. Announces Reverse Stock Split of Common Stock
14 Jan 20
8-K
Regulation FD Disclosure
6 Dec 19
8-K
Submission of Matters to a Vote of Security Holders
8 Oct 19
Registration and prospectus
D
$500K in debt / options / securities to be acquired / Convertible debt, sold $200K, 5 investors
30 Sep 21
15-15D
Suspension of duty to report
11 Aug 21
POS AM
Prospectus update (post-effective amendment)
5 Aug 21
RW
Registration withdrawal request
10 Mar 21
S-1/A
IPO registration (amended)
22 Nov 19
S-1/A
IPO registration (amended)
27 Sep 19
S-1
IPO registration
14 Aug 19
424B3
Prospectus supplement
7 Feb 19
S-1/A
IPO registration (amended)
4 Jan 19
S-1
IPO registration
14 Dec 18
Proxies
No filings
Other
EFFECT
Notice of effectiveness
10 Aug 21
UPLOAD
Letter from SEC
20 Jul 20
CORRESP
Correspondence with SEC
30 Jun 20
UPLOAD
Letter from SEC
16 Jun 20
CORRESP
Correspondence with SEC
5 Jun 20
UPLOAD
Letter from SEC
21 May 20
EFFECT
Notice of effectiveness
8 Feb 19
EFFECT
Notice of effectiveness
25 Jun 18
CT ORDER
Confidential treatment order
7 Nov 17
EFFECT
Notice of effectiveness
9 Feb 17
Ownership